Pancreatic cancer is a highly malignant gastrointestinal tumor with high invasiveness, easy metastasis, and poor chemoresistance. Surgery is still the preferred treatment for resectable pancreatic cancer. At present, inflammatory scoring systems based on serological indicators in patients with resectable pancreatic cancer can be divided into two types: the inflammatory scoring system based on c-reactive protein albumin and the inflammatory scoring system based on peripheral blood cell count. However, the specific mechanism between these inflammatory markers and the prognostic value of resectable pancreatic cancer remains unclear. This article reviews the correlation between systemic inflammatory response indexes and prognosis of patients with resectable pancreatic cancer, so as to provide help for the comprehensive treatment of pancreatic cancer.
No takes yet. Share an insight, caveat, or question.
Jia et al. (2019) studied this question.